What Is a Thyroid Adenoma? Symptoms and Treatment

A thyroid adenoma is a benign (noncancerous) growth that forms in the thyroid gland, a butterfly-shaped organ at the base of your neck that regulates metabolism, heart rate, and body temperature. Most thyroid adenomas produce no symptoms at all and are discovered incidentally during imaging for something else. When they do cause problems, the trouble usually falls into one of two camps: the adenoma grows large enough to press on nearby structures, or it starts churning out thyroid hormone on its own, tipping you into hyperthyroidism. Understanding which category yours falls into shapes almost every decision about monitoring and treatment.

How a Thyroid Adenoma Differs from Other Nodules

Thyroid nodules are extremely common. Most are colloid nodules or cysts, essentially benign lumps of normal thyroid tissue or fluid that pose no real threat. A thyroid adenoma is a specific type of benign nodule: a true neoplasm, meaning it arises from the abnormal growth of a single clone of thyroid cells. Follicular adenomas, the most common subtype, are made up of the same follicular cells that produce thyroid hormone in healthy tissue. What sets an adenoma apart from a simple nodule is that it has a distinct capsule surrounding it, giving it clear borders on imaging and under the microscope.

The critical clinical challenge is that a follicular adenoma can look nearly identical to a follicular carcinoma, its malignant counterpart. A follicular carcinoma cannot be reliably distinguished from a follicular adenoma based on cytology, ultrasound, or clinical features alone.¹ The difference comes down to whether tumor cells have invaded through the capsule or into blood vessels, something a needle biopsy typically cannot determine. This is why many patients with a follicular neoplasm end up having part of the thyroid surgically removed just to get a definitive answer.

Functioning Versus Non-Functioning Adenomas

The single most important distinction your doctor will make is whether the adenoma is “hot” or “cold” on a thyroid scan. These terms describe whether the nodule is actively taking up radioactive tracer, which correlates with hormone production.

Hot (toxic) adenomas: These produce thyroid hormone independently of your body’s normal feedback signals. They are sometimes called autonomously functioning thyroid nodules. The excess hormone can cause hyperthyroidism, with symptoms like a rapid heartbeat, weight loss, tremors, heat intolerance, and anxiety.
Cold (non-functioning) adenomas: These do not produce significant amounts of hormone on their own. They show up as areas of reduced tracer uptake on a scan. Most thyroid adenomas fall into this category and are hormonally silent, meaning they do not disrupt your thyroid levels.

The reason hot adenomas behave this way traces back to their genetics. Somatic mutations that permanently switch on the TSH receptor are the major cause of benign toxic thyroid adenomas.² Research has found activating mutations in roughly 80% of toxic adenomas studied, with the remainder likely driven by mutations in a related signaling protein.³ In a toxic nodule, the clinical picture of hyperthyroidism paired with autonomous growth of the nodule points to chronic overactivation of the cell’s internal growth-and-hormone pathway.⁴

Symptoms That Bring People to the Doctor

Many thyroid adenomas never produce symptoms and are found by accident when you have a neck ultrasound, CT scan, or even a carotid artery exam for an unrelated reason. When symptoms do appear, they generally stem from one of two mechanisms: the adenoma making too much hormone, or the adenoma getting large enough to physically push on things in your neck.

Hyperthyroid Symptoms from a Toxic Adenoma

If the adenoma is autonomously producing thyroid hormone, you may notice a constellation of symptoms tied to a revved-up metabolism. A fast or irregular heartbeat, unintentional weight loss despite a normal or increased appetite, feeling jittery or anxious, sweating more than usual, difficulty sleeping, and muscle weakness are all common. Some people notice their hands trembling when they hold them out flat. These symptoms tend to build gradually over months, which is why they are often chalked up to stress or aging before anyone checks thyroid levels.

Compressive Symptoms from a Growing Nodule

Larger nodules, whether hormonally active or not, can press on the esophagus, trachea, or surrounding tissues. In a study of patients with thyroid nodules, the average size of nodules causing compressive symptoms was about 3.8 cm, compared to roughly 2.2 cm for those not causing any problems.⁵ The most frequently reported symptom was difficulty swallowing, affecting about 80% of symptomatic patients, followed by a sense of neck fullness, a choking sensation, and shortness of breath.⁵

Thyroid nodules can cause swallowing trouble by directly compressing the esophagus, something that can sometimes be visualized on ultrasound.⁶ Another study found that shortness of breath was specifically linked to tracheal compression and deviation, while hoarseness occurred in about 10% of symptomatic patients with benign thyroid disease.⁷ Visible swelling at the front of the neck was present in about two-thirds of patients with compressive symptoms, compared to only about 15% of those without symptoms.⁵

How Thyroid Adenomas Are Diagnosed

Diagnosis typically involves a combination of blood work, imaging, and sometimes a biopsy. Each step narrows the possibilities in a different way.

The first step is usually a blood test measuring TSH (thyroid-stimulating hormone). If your TSH is low, it suggests the thyroid is producing too much hormone, which raises suspicion for a toxic adenoma. Normal TSH in the context of a nodule suggests it is non-functioning.

Ultrasound is the workhorse imaging tool. It shows the size, shape, composition, and borders of the nodule. Benign nodules tend to have a thin, uniform halo, a rim of tissue around the edge. Research on this halo sign found that benign nodules typically had a thin, uniform halo, while malignant nodules tended to have halos that were uneven or absent.⁸ Ultrasound has become an essential tool for endocrinologists, providing sensitive and specific malignancy risk prediction for thyroid nodules.⁹ That said, ultrasound alone cannot definitively tell a benign adenoma from a cancer.

When TSH is low and a functioning nodule is suspected, a thyroid scintigraphy scan (sometimes called a nuclear medicine scan) can determine whether a nodule is truly “hot.” This scan uses a small amount of radioactive iodine or technetium. A hot nodule lights up intensely, confirming it is autonomously producing hormone, while the rest of the gland often appears suppressed.¹⁰ In rare cases, a nodule can appear hot on a technetium scan but cold on an iodine scan, which can create diagnostic confusion.¹¹

Fine-Needle Aspiration and Molecular Testing

For nodules that are not clearly hot, a fine-needle aspiration biopsy is often the next step. A thin needle is inserted into the nodule under ultrasound guidance, and a small sample of cells is withdrawn for examination under a microscope. This procedure is quick and generally well tolerated.

The challenge arises when biopsy results come back as “indeterminate,” meaning the cells look abnormal but the pathologist cannot say for certain whether they are benign or malignant. This happens in a meaningful percentage of biopsies and used to automatically mean surgery. Today, molecular testing platforms can analyze the biopsy sample for genetic mutations and gene expression patterns to better estimate cancer risk. Nodules found suspicious on imaging can be biopsied by fine-needle aspiration, which yields material for molecular testing to refine the diagnosis.¹² Testing for DNA, messenger RNA, and microRNA together can accurately classify benign and malignant thyroid nodules, improving the preoperative management of indeterminate cases.¹³ These molecular tools are now recognized as a standard option in national clinical guidelines.¹⁴

One wrinkle worth knowing: activating mutations in the RAS family of genes can appear across a spectrum from completely benign follicular adenomas (in about a quarter of cases) all the way to malignant follicular thyroid carcinomas (in 40–50%).¹⁵ Finding a RAS mutation does not mean cancer, but it does mean closer scrutiny is warranted. Researchers have identified a panel of six genes whose expression levels, combined with nodule size, can predict whether a RAS-mutant nodule is invasive with high accuracy.¹⁵

Treatment Options

How a thyroid adenoma is treated depends on its size, whether it is producing excess hormone, whether it is causing compressive symptoms, and how confident doctors are that it is truly benign.

Observation

Small, non-functioning adenomas that are not causing symptoms and look benign on imaging and biopsy may not need treatment at all. Your doctor may recommend periodic ultrasound checks, perhaps every 12 to 24 months, to watch for growth. Many of these nodules remain stable for years or even shrink on their own.

Surgery

Surgical removal, usually a thyroid lobectomy (taking out the half of the thyroid that contains the adenoma), is the standard treatment in several scenarios. If the biopsy is indeterminate and molecular testing does not rule out cancer, surgery provides the definitive answer. A lobectomy is also definitive treatment for both a benign follicular adenoma and a minimally invasive follicular cancer.¹ Large adenomas causing compressive symptoms are another common reason for surgery.

One concern people have about thyroid surgery is its effect on the voice. Research on voice changes after lobectomy in adenoma patients found that while vocal pitch dropped in the first week after surgery, values returned to normal by three months.¹⁶ Vocal cord function was normal before and after surgery in all patients in that study, suggesting that the temporary voice changes reflected tissue swelling and healing rather than nerve damage. Permanent voice changes are possible but uncommon when surgery is performed by experienced thyroid surgeons.

Radioactive Iodine

For toxic adenomas causing hyperthyroidism, radioactive iodine (I-131) is a well-established alternative to surgery. The concept is straightforward: since the overactive nodule is avidly taking up iodine, a therapeutic dose of radioactive iodine is selectively absorbed by the adenoma, gradually destroying it while sparing much of the surrounding normal tissue. Radioactive iodine has been widely used for therapy of toxic adenomas and is now accepted as safe and effective even in children.¹⁷ The main downside is that some patients develop hypothyroidism afterward and need lifelong thyroid hormone replacement, though this is less common with a single toxic adenoma than with treatment for Graves’ disease.

Radiofrequency Ablation

Radiofrequency ablation (RFA) has emerged as a minimally invasive option for benign thyroid nodules that are causing symptoms or cosmetic concerns. A needle-like probe is inserted into the nodule under ultrasound guidance, and heat energy destroys the tissue from within. The nodule then gradually shrinks over the following months as the body reabsorbs the treated tissue.

A study of RFA for large benign thyroid nodules found that a single session reduced nodule volume by roughly two-thirds at six months. Patients who underwent a second session within six months achieved significantly greater shrinkage at 12 months, with an average volume reduction of about 76% compared to about 66% with a single session.¹⁸ RFA has also been used to treat compressive nodules causing swallowing difficulty, avoiding surgery entirely in some patients.⁶ RFA does not provide tissue for pathological analysis the way surgery does, so it is only appropriate when the nodule has been confirmed as benign. It also does not eliminate the nodule entirely, which means ongoing monitoring is still needed.

Anti-Thyroid Medications

Drugs like methimazole can be used to control hyperthyroidism caused by a toxic adenoma, but they do not shrink the nodule or cure the underlying problem. They are most useful as a short-term bridge, bringing hormone levels under control before surgery or radioiodine treatment, or for people who are not candidates for those definitive therapies.

The Anxiety Factor

One aspect of thyroid nodules that gets less attention than it deserves is the psychological toll of having a lump in your neck that might or might not be cancer. The waiting period between discovery and definitive diagnosis can stretch weeks or months, and that uncertainty takes a measurable toll. A large retrospective study found that patients with thyroid nodules had a slightly but consistently higher risk of developing anxiety compared to patients who actually had thyroid cancer.¹⁹ That finding seems paradoxical until you consider that a cancer diagnosis, while alarming, also comes with a clear treatment plan. Living with an indeterminate nodule means living with ambiguity.

Molecular testing has helped on this front. Research examining quality of life found that patients whose molecular test results came back benign had preserved quality-of-life scores, while those with suspicious or positive results experienced worse anxiety, depression, and goiter-related symptoms.²⁰ In other words, getting a clear benign result on molecular testing does not just spare you surgery; it can measurably improve your mental health during the monitoring period.

When an Adenoma Needs a Second Look

Even after an adenoma is diagnosed as benign, there are situations where your doctor may want to reassess. Growth of more than 20% in two dimensions on follow-up ultrasound, new symptoms like voice changes or difficulty breathing, or a shift in blood work can all prompt a repeat biopsy or a recommendation for surgery. A non-functioning adenoma can, in rare cases, start producing hormone over time, converting from cold to hot. And while the transformation of a benign adenoma into a cancer is considered uncommon, the difficulty of distinguishing the two on initial biopsy means some adenomas that were initially called benign are reclassified after surgical removal when a pathologist can examine the full capsule.

For toxic adenomas that are being monitored rather than treated, worsening hyperthyroidism can put strain on your heart over time, particularly if you are older or already have cardiac issues. This is one reason doctors tend to recommend definitive treatment with radioiodine or surgery for toxic adenomas rather than indefinite observation, even when symptoms seem mild.

The Overdiagnosis Debate

The widespread use of thyroid ultrasound has been a double-edged sword. On one hand, it catches clinically relevant nodules earlier and with better characterization. On the other, the technology is so sensitive that it picks up tiny nodules that would never have caused problems. This has led to a well-documented wave of overdiagnosis, where people undergo biopsies, molecular tests, follow-up scans, and sometimes even surgery for nodules that posed no real threat to their health. The psychological burden described above is part of this cost. The evidence confirms that while ultrasound has proven invaluable for diagnostic purposes, its extensive use has also resulted in important negative consequences.⁹

Current guidelines try to strike a balance by recommending biopsy only for nodules above a certain size threshold or with suspicious features on ultrasound. If you have been told you have a small thyroid nodule that looks benign and your thyroid function is normal, there is a reasonable chance that the best course of action is simply to keep an eye on it and resist the urge to intervene. The improved molecular tools now available make it easier to identify which indeterminate nodules truly warrant surgery and which can safely be watched, sparing a growing number of patients from operations they did not need.

1
PubMed Central. Follicular adenoma and carcinoma of the thyroid gland
2
Trends in Endocrinology & Metabolism. Mutations of the thyrotropin receptor and disease
3
PubMed. Activating mutations of the TSH receptor gene cause thyroid diseases
4
PubMed. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism
5
PubMed Central. Does nodule size predict compressive symptoms in patients with thyroid nodules?
6
International Journal of Thyroidology. Diagnosing Dysphagia Due to Thyroid Nodules by Thyroid Ultrasound, a Case Series
7
PubMed. How radiologic/clinicopathologic features relate to compressive symptoms in benign thyroid disease
8
PubMed Central. Sonographic characteristics of thyroid nodules with a Halo
9
PubMed. The History of Thyroid Ultrasound: Past, Present, and Future Directions
10
PubMed. Thyroid functional and molecular imaging
11
PubMed. Association of hyperfunctioning thyroid adenoma with thyroid cancer presenting as “trapping only” nodule at 99mTcO4- scintigraphy
12
PubMed. Molecular testing in fine-needle aspiration of thyroid nodules
13
PubMed Central. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology
14
PubMed Central. The Role of Molecular Testing for the Indeterminate Thyroid FNA
15
PubMed Central. Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility
16
PubMed. A voice acoustic analysis of thyroid adenoma patients after a unilateral thyroid lobectomy
17
PubMed Central. Autonomous Functioning Thyroid Nodule in a 4-year-old Male Child Treated with Radioiodine (I-131)
18
Surgery. Early second radiofrequency ablation treatment gave rise to significantly greater nodule shrinkage at 12 months than single-session treatment for large-volume benign thyroid nodules
19
PubMed Central. Anxiety disorders in patients with thyroid nodules vs. thyroid cancer: a retrospective cohort study
20
PubMed Central. A Scoping Review of Patient Health-Related Quality of Life Following Surgery or Molecular Testing for Individuals with Indeterminate Thyroid Nodules